Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Infection and Response to COVID-19 Vaccination in Patients With Primary Immunodeficiencies
Robert Paris
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_1, pp. S24-S33
Open Access | Times Cited: 9

Showing 9 citing articles:

Shielding the immunocompromised: COVID-19 prevention strategies for patients with primary and secondary immunodeficiencies
G. Olivieri, Donato Amodio, Emma Concetta Manno, et al.
Vaccine (2025) Vol. 51, pp. 126853-126853
Open Access
The Impact of the COVID-19 Omicron Variant on Immunocompromised Patients: ICU Admissions and Increased Mortality
Jan Pander, Fabian Termorshuizen, Dylan W. de Lange, et al.
Infectious Diseases and Therapy (2025)
Open Access
When Cell-Mediated Immunity after Vaccination Is Important
Roberto Paganelli
Pathogens (2024) Vol. 13, Iss. 1, pp. 65-65
Open Access | Times Cited: 1
Charting a course for global progress in PIDs by 2030 — proceedings from the IPOPI global multi-stakeholders’ summit (September 2023)
Samya Van Coillie, J Prévot, Silvia Sánchez‐Ramón, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Estimating the population-level effects of nonpharmaceutical interventions when transmission rates of COVID-19 vary by orders of magnitude from one contact to another
Richard P. Sear
Physical review. E (2024) Vol. 110, Iss. 6
Open Access | Times Cited: 1
Clinical efficacy of SARS‐CoV‐2 Omicron‐neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency
Michael Karbiener, Gerhard Kindle, Isabelle Meyts, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 6
Open Access
Safety of Nirmatrelvir-Ritonavir Administration in Children With Immunodeficiency and/or Comorbidities With SARS-CoV-2 Infection: A Retrospective Clinical Report
Stefania Bernardi, Marco Roversi, Antonio Torelli, et al.
The Pediatric Infectious Disease Journal (2024)
Closed Access
A community study of neutralizing antibodies against SARS-CoV-2 in China
Yitong Lv, Lei Huang, Junhu Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic
Giulia Costanzo, Carla Maria Deiana, Giuseppina Sanna, et al.
Journal of Clinical Immunology (2023) Vol. 44, Iss. 1
Closed Access | Times Cited: 1
Foreword: Preventing COVID-19 Among the Immunocompromised Population
Michelle Willicombe
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_1, pp. S1-S3
Open Access
Page 1

Scroll to top